Your browser doesn't support javascript.
loading
Electrophoresis-Mediated Characterization of Full and Empty Adeno-Associated Virus Capsids.
Coll De Peña, Adriana; Masto, Lucy; Atwood, James; Tripathi, Anubhav.
Afiliação
  • Coll De Peña A; Center for Biomedical Engineering, School of Engineering, Brown University, Providence, Rhode Island 02912, United States.
  • Masto L; Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912, United States.
  • Atwood J; Applied Genomics, PerkinElmer, Hopkinton, Massachusetts 01748, United States.
  • Tripathi A; Center for Biomedical Engineering, School of Engineering, Brown University, Providence, Rhode Island 02912, United States.
ACS Omega ; 7(27): 23457-23466, 2022 Jul 12.
Article em En | MEDLINE | ID: mdl-35847322
Adeno-associated virus (AAV) has shown great potential in gene therapy due to its low immunogenicity, lack of pathogenicity to humans, and ability to provide long-term gene expression in vivo. However, there is currently a need for fast, high-throughput characterization systems that require low volumes for the determination of its sample composition in terms of full and empty capsids since empty capsids are a natural byproduct of AAV synthesis. To address this need, the following study proposes a high-throughput electrophoresis-mediated microfluidics approach that is independent of sample input concentration to estimate the composition of a given sample by combining its protein and ssDNA information relative to a standard. Using this novel approach, we were able to estimate the percentage of full capsids of six AAV8 samples with an average deviation from the actual percentage of 4%. The experiments used for these estimations were conducted with samples of varying percentages of full capsids (21-75%) and varying concentrations (5 × 1011-1 × 1012 VP/mL) with a total volume requirement of 3-10 µL for triplicate analysis of the sample. This method offers a rapid way to evaluate the quality and purity of AAV products. We believe that our method addresses the critical need as recognized by the gene and molecular therapy community.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article